Advanced Eye Imaging for Glaucoma and Other Disorders

oCular Examination at Cell RESolution With Optical TransmissionTomography

Recruiting N/A Interventional Study
Glaucoma Associated With Other Ocular Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
300 (estimated)
Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts · Other
Who this trial is looking for

This trial is looking for individuals aged 18 to 80 to participate in eye imaging research. Participants will help test a new imaging technology for eye conditions like glaucoma and cataracts.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 80 years old
  • I have an eye disease affecting my cornea, lens, or glaucoma
  • I need refractive surgery or follow-up after such surgery
  • I am covered by the French Assurance Maladie
  • I have signed a consent form

You may not be able to join if

  • I cannot hold still during the exam
  • I have an active eye infection or contagious disease
  • I have an implanted pacemaker or electronic medical device
  • I have a condition that might cause my eye pressure to increase
  • I am pregnant or breastfeeding
  • I am under legal protection

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transm…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For Patients: * 200 subjects aged 18 to 80 years; * Male or female; * with an ocular disease affecting the cornea, ocular surface, lens (cataract) or glaucoma, or requiring refractive surgery or post-refractive surgery follow-up; * Are covered by the French Assurance Maladie; *…
Contacts

Nabil BROUK

00 33 1 40 02 11 44

nbrouk@15-20.fr

CONTACT